It is widely accepted that human papillomavirus (HPV) is the primary causative agent of cervical neoplasia (cervical intraepi thelial neoplasia [CIN] and invasive cancer) (zur Hausen, 1991) . However, HPV infection of the uterine cervix does not always induce cellular abnormalities (de Villiers et al, 1987) , suggesting that other factors play a role in the development of cervical neoplasia. Many epidemiologic factors have been suggested as relevant to the development of cervical neoplasia (Rotkin, 1973; Bornstein et al, 1995) . We conducted a case-control study to clarify how epidemiologic factors are involved in the development of CIN in relation to HPV infection.
The questionnaire
Information concerning health issues related to the possible aetiology of CIN was obtained by a self-administered questionnaire. The questionnaire, which included demographic factors, smoking habits, contraceptive and reproductive history, and sexual behaviour, was distributed to each case or control on their second hospital visit. Several participants gave no answers to certain questions.
Detection and typing of HPV
Cellular DNA was extracted from cervical exfoliated cells by standard procedure. We used the consensus L1 primers, L1C1 (1 µM), L1C2 (0.5 µM) and L1C2M (0.5 µM), for the polymerase chain reaction (PCR) (Yoshikawa et al, 1991) . HPV types were identified on the basis of the restriction fragment length polymorphism. The assay can type at least 26 genital HPVs. HPV data were not obtained from nine (5%) of CIN cases and 37 (22%) of controls. HPV types were categorized into three groups of carcinogenic potency according to then risk classification proposed by Lorincz et al, (1992) ; i.e. high-, intermediate-and low-risk HPVs (Table 1) .
Blood sampling and serum antibody detection
A blood sample for serological assays of herpes simplex virus (HSV), cytomegalovirus (CMV) and Chlamydia trachomatis (CT) was collected from each subject. Blood sampling was not available in 9 (5%) CIN cases and 5 (3%) controls. Antibodies were assayed by using commercially available enzyme-linked immunosorbent assay (ELISA) kits; HSV and CMV (Denkaseiken, Niigata, Japan), and CT (Labsystems Oy, Helsinki, Finland).
Data analysis
Odds ratios (ORs) and the corresponding 95% confidence intervals (Cls) were calculated for each variable using conditional Human papillomavirus infection and other risk factors for cervical intraepithelial neoplasia in Japan logistic regression technique. Continuous variables were categorized to allow ORs to be computed. Alongside crude ORs, we calculated ORs after adjustment for HPV infection (HPV-adjusted ORs). HPV infection and HPV-independent variables were assessed by multivariate analysis. Tests for linear trend were mainly performed on continuous variables. All the abovementioned statistical analyses were done using the SAS computer software package (SAS Institute, Cary, NC, USA). Association between two variables was analysed using a Spearman rank correlation coefficient.
RESULTS
The mean ages of CIN cases and controls were 40.3 years and 40.7 years respectively. The age distribution was almost the same in the two groups.
HPV infection
HPV DNA was detected much more frequently in CIN cases than controls (Tables 1 and 2 , OR ϭ 30.0). The incidence and types of HPV detected in CIN cases and controls are shown in Table 1 . In the case of CIN as a whole, and high-grade CIN, no significant differences in ORs were found across the three HPV subgroups with different carcinogenic potentials ( Table 2) .
Risk factors before and after adjustment for HPV infection
Of 16 study variables, the following nine showed statistically significant differences between cases and controls before adjustment for HPV infection: smoking, being married, early age at marriage, multiple pregnancies, multiparity, early age at first pregnancy, multiple sexual partners, positive CT IgA and positive CT IgG (Tables 3 and 4) . Most of these risk factors were no longer significant after adjustment and, in particular, the elevated risks associated with smoking and multiple sexual partners disappeared completely (HPV-adjusted OR Ͻ 1.0). In contrast, the associations between being married, multiparity and early age at first pregnancy with CIN risk remained significant after adjustment.
The multivariate analysis for HPV infection and the three HPVindependent variables confirmed that these factors were independently and significantly associated with the risk of CIN (HPV infection, OR ϭ 113; currently being married, OR ϭ 8.75, three or more births, OR ϭ 4.00; 23 years or younger at first pregnancy OR ϭ 7.79).
DISCUSSION
The present study confirmed that the highest risk determinant for CIN was HPV infection. As expected, CIN patients had various habitual, reproductive and sexual risk factors. However, these factors, except for multiparity, early age at first pregnancy and being married, were no longer significant after adjustment for HPV infection.
The independent role of multiparity for development of CIN in our study is of particular interest. Several recent studies controlling for HPV infection have also observed an association between multiparity and risk of CIN (Schiffman et al, 1993; Becker et al, 1994) . It was reported that progesterone enhances expression of E6 and E7 oncoproteins through progesterone-responsive elements of HPV (Chen et al, 1996) . In addition, there is a recent report suggesting that progesterone may impair T-cell recognition of HPV-infected cells (Bartholomew et al, 1997) . It seems likely that higher levels of progesterone derived from the placenta may be associated with CIN development.
Early age at first pregnancy has not been consistently shown to be a risk factors in the previous studies. As expected, this factor was closely correlated with early age at first birth (Spearman rank correlation coefficient ϭ 0.87, P ϭ 0.0001). In a British study, early age at first birth was associated with an enhanced risk of high-grade CIN (Cuzick et al, 1990 ). This factor was found to be independent of multiparity and marital status in the multivariate analysis. Thus, it is conceivable that the uterine cervix of young pregnant women, mostly in concert with HPV, is more vulnerable to the development of CIN. Being married was found to be a HPV-independent risk factor for CIN in this study. This factor was firstly described as a risk factor of cervical cancer in Rigoni-Stern's study in 1842 (Rotkin, 1973) . It is to be noted that marital status was a risk factor independent of multiparity in the multivariate analysis.
It is of interest that smoking was no longer a risk factor of CIN after adjustment for HPV infections as in several recent studies (Schiffman et al, 1993; Olsen et al, 1995) . Other lines of research have documented smoking as a risk factor for high-grade CIN (Kjaer et al, 1998; Olsen et al, 1998) , and the present data do not rule out the possibility that smoking is a risk factor for CIN progression.
Lifetime number of sexual partners and age at first intercourse turned out not to be risk factors after controlling for HPV infection. This suggests that sexual behaviour per se may be a risk factor of HPV infection but not CIN, in keeping with previous studies (Schiffman et al, 1993; Becker et al, 1994) .
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British Journal of Cancer (1999) 80(3/4) , 621-624 © Cancer Research Campaign 1999 Thus far, a limited number of studies have carried out serological analyses for sexually transmitted agents in the search of risk factors of CIN. Certain studies found an independent role of antibodies against CT or CMV as risk factors for high-grade CIN (Koutsky et al, 1992; de Sanjose et al, 1994 ). Here we demonstrated that the serological markers of HSV, CMV and CT were not HPV-independent risk factors for CIN as in another recent study (Ferrera et al, 1998) .
In the present study, we focused on the analysis of risk factors in the development of CIN. The results yield clues toward elucidating the mechanism of the development of CIN in conjunction with HPV. It is to be noted that risk factors for the progression of CIN to cervical cancer may be different from those for CIN development. To elucidate aetiologic factors for CIN progression, a cohort study is underway.
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